In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Intergen Co.

Division of EMD Millipore/Serologicals Corp.

Latest From Intergen Co.

Vysis Preps For Prime Time

Tiny Vysis scored big this spring, winning the backing of two major therapeutic and diagnostic companies for its products. But is its core technology ready for prime time? Vysis sees an opportunity to expand use of its FISH diagnostics technology beyond niche applications in the clinical market. But skeptics say the technology is too complex and expensive for routine clinical use.
BioPharmaceutical Medical Device

Tough Times for Small Diagnostics Companies

The sad saga of Oncor Inc. is slowly coming to an end, with the purchase in November of its {in situ} hybridization business by Ventana Medical Systems Inc.
Medical Device
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register